PLA2G5

protein-coding

phospholipase A2 group V, the group of Phospholipases

Gene summary

This gene is a member of the secretory phospholipase A2 family. It is located in a tightly-linked cluster of secretory phospholipase A2 genes on chromosome 1. The encoded enzyme catalyzes the hydrolysis of membrane phospholipids to generate lysophospholipids and free fatty acids including arachidonic acid. It preferentially hydrolyzes linoleoyl-containing phosphatidylcholine substrates. Secretion of this enzyme is thought to induce inflammatory responses in neighboring cells. Alternatively spliced transcript variants have been found, but their full-length nature has not been determined. [provided by RefSeq, Jul 2008]

MANE transcript

NM_000929.3

Inheritance

AR

ClinVar variants

P:4U:87B:27

Top phenotype

Fleck retina, familial benign

gnomAD constraint

pLI —, LoF o/e 0.85

Max pathogenic AF

—

Genomic locus

chr1:20,028,179-20,091,911

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~63.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

familial benign flecked retinaLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0009235

Submitter: Ambry Genetics

familial benign flecked retinaSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009235

Submitter: Orphanet

familial benign flecked retinaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009235

Submitter: PanelApp Australia

late-adult onset retinitis pigmentosaLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0009984

Submitter: Franklin by Genoox

A index patient was diagnosed with late-onset RP at the age of 88. WES revealed a homozygous PLA2G5 frameshift mutation.

familial benign flecked retinaDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009235

Submitter: G2P

Clinical Genomic Database (CGD)

Fleck retina, familial benignAR

Manifestation: Ophthalmologic

Intervention: General

Rationale: The clinical relevance of the condition is unclear

Refs: 8703867; 17502520; 22137173Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to PLA2G5 variants in ClinVar

6 Conditions Cataloged
not providedTotal: 128
not specifiedTotal: 32
Familial benign flecked retinaTotal: 6
PLA2G5-related disordersTotal: 2
Late-onset retinal degenerationTotal: 1
Retinal disorderTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000929.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
21
clinvar
1
clinvar
25
missense
1
clinvar
71
clinvar
5
clinvar
77
nonsense
1
clinvar
6
clinvar
7
start loss
1
clinvar
1
frameshift
1
clinvar
6
clinvar
7
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total2287261118

Highest pathogenic variant AF is 0.000027259199

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 144 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000929.3RefSeqNP_000920.14MANE Select
ENST00000375108.4EnsemblENSP00000364249.34MANE Select
ENST00000894073.1EnsemblENSP00000564132.14Standard
ENST00000894073.2EnsemblENSP00000564132.14Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Ether lipid metabolism - Homo sapiens (human)
  • Glycerophospholipid metabolism - Homo sapiens (human)
  • Fat digestion and absorption - Homo sapiens (human)
  • Vascular smooth muscle contraction - Homo sapiens (human)
  • alpha-Linolenic acid metabolism - Homo sapiens (human)

Biological Process

  • phospholipid metabolic process
  • phosphatidic acid biosynthetic process
  • platelet activating factor biosynthetic process
  • positive regulation of phospholipase activity
  • lipid catabolic process

Molecular Function

  • phospholipase A2 activity
  • calcium ion binding
  • phospholipid binding
  • heparin binding
  • calcium-dependent phospholipase A2 activity

Cellular Component

  • extracellular region
  • Golgi apparatus
  • plasma membrane
  • cell surface
  • perinuclear region of cytoplasm

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000375108
Coding exons
4
Length
63012
Individuals with no LoFs
125729
Homozygous LoFs
0
Heterozygous LoFs
16
Defined
125745
p
0.0000636
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.2738289.30.9190.00000569889
Missense (PolyPhen)2433.2270.72231358
Synonymous0.9693037.50.7990.00000264263
Loss of Function0.39178.210.8534.36e-781

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000250.00025rare
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish00.0absent
East Asian0.000110.00011rare
Finnish00.0absent
European (Non-Finnish)0.0000620.000062rare
South Asian0.0000650.000065rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides. This isozyme hydrolyzes more efficiently L-alpha-1-palmitoyl-2-oleoyl phosphatidylcholine than L-alpha-1-palmitoyl-2-arachidonyl phosphatidylcholine, L- alpha-1-palmitoyl-2-arachidonyl phosphatidylethanolamine, or L- alpha-1-stearoyl-2-arachidonyl phosphatidylinositol. May be involved in the production of lung surfactant, the remodeling or regulation of cardiac muscle.;
Disease
DISEASE: Fleck retina, familial benign (FRFB) [MIM:228980]: An autosomal recessive condition associated with a distinctive retinal appearance and no apparent visual or electrophysiologic deficits. Affected individuals are asymptomatic, but fundus examination reveals a striking pattern of diffuse, yellow-white, fleck-like lesions extending to the far periphery of the retina but sparing the foveal region. {ECO:0000269|PubMed:22137173}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

LoFtool
0.588
RVIS EVS
-0.32
RVIS percentile EVS
31.46

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.171

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.